✉news ScienceBiology first seen 12 h ago, last 1 h ago, peak #8
CellsBin Raises Series A Funding Led By 108 BioCapital
Original: CellsBin Raises Series A Led By 108 BioCapital To Advance Rare-Cell Intelligence Platform
CellsBin has raised a Series A round led by 108 BioCapital to advance its rare-cell intelligence platform. The company develops technology for detecting and analyzing rare cells, an area of growing interest in diagnostics and life sciences research. The funding is expected to support further development of its platform as investor attention on biology and precision-medicine tools continues to build.
Why now: The funding round signals continued investor confidence in biotech platforms for rare-cell analysis.
Rank over time, top of the chart is #1. 3 snapshots from 4 h ago to 1 h ago.
Evidence
- CellsBin Raises Series A Led By 108 BioCapital To Advance Rare-Cell Intelligence Platform · Pulse 2.0
API: https://socialmediatrends-api.osmike.com/v1/trends/736237